Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo

This publication has 12 references indexed in Scilit:

• Bayesian Design and Analysis of Active Control Clinical Trials
  Biometrics, 1999
• One Large, Well-Designed, Multicenter Study as an Alternative to the Usual Fda Paradigm
  Drug Information Journal, 1999
• When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?
  Controlled Clinical Trials, 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
  The Lancet, 1995
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986
• Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)
  Journal Of Hypertension, 1985
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
  BMJ, 1985
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985